Cryoablation triggers type I interferon-dependent antitumor immunity and potentiates immunotherapy efficacy in lung cancer
The immune system mistakenly attacks the joints, leading to inflammation and tissue damage
To date, these conclusions have mostly been drawn from retrospective studies and meta-analyses, and prospective studies are warranted to validate these findings
10.1042/CS20160897 132 Gomez Del ArcoP.Martnez-MartnezS.CalvoV.ArmesillaA
Enbrel and Remicade), p38 inhibitors, adenosine Al receptor agonists (e.g., R-PIA), somatostatin analogs, semapimod (CNI1493), caspase inhibitors, STAT inhibitors, JAK inhibitors, Trp channel inhibitors (e.g., BCTC), MET channel and other ion channel inhibitors, OCT2 transporter inhibitors (e.g., trospium chloride), CTR1 transporter inhibitors, and inhibitors of cyclin-dependent kinases, including CDK2 inhibitors